A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness
Public ClinicalTrials.gov record NCT06803654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness
Study identification
- NCT ID
- NCT06803654
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 578 participants
Conditions and interventions
Conditions
Interventions
- BTOS-HA Drug
- Lumify® Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2025
- Primary completion
- Jun 28, 2025
- Completion
- Jun 28, 2025
- Last update posted
- May 27, 2026
2025
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 102 | Glendale | California | 91204 | — |
| Site 104 | Newport Beach | California | 92663 | — |
| Site 111 | Northbrook | Illinois | 60062 | — |
| Site 109 | Pittsburg | Kansas | 66762 | — |
| Site 106 | Louisville | Kentucky | 40206 | — |
| Site 103 | Andover | Massachusetts | 01810 | — |
| Site 108 | Garner | North Carolina | 27529 | — |
| Site 107 | Shelby | North Carolina | 28150 | — |
| Site 112 | Cranberry Township | Pennsylvania | 16066 | — |
| Site 101 | Memphis | Tennessee | 38119 | — |
| Site 105 | Smyrna | Tennessee | 37167 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06803654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06803654 live on ClinicalTrials.gov.